Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis

Joonhong Sohn, Tae-im Kim, Young Hee Yoon, Joo Yong Kim, Soo Youl Kim

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Steroidal anti-inflammatory drugs induce proteins that inhibit phospholipase A2 (PLA2), including uteroglobin and lipocortin-1 (annexin I). Uteroglobin and lipocortin-1 retain several conserved sequences. Based on these sequences, several nonapeptides (antiflammins) were synthesized. These nonapeptides were shown to have anti-inflammatory effects in vitro and in vivo, possibly by inhibiting PLA2. Subsequent research showed that PLA2 is activated by transglutaminase 2 (TGase 2). We hypothesize here that TGase 2 inhibitors may increase the anti-inflammatory efficacy of inhibiting PLA2 activity. To test this theory, we constructed recombinant peptides containing sequences from pro-elafin (for inhibition of TGase 2), and from lipocortin-1, lipocortin-5, and uteroglobin (for inhibition of PLA2). The recombinant peptides, which had dual inhibitory effects on purified TGase 2 and PLA2, reversed the inflammation of allergic conjunctivitis to ragweed in a guinea pig model. The present work suggests that novel recombinant peptides may be safe and effective agents for the treatment of various inflammatory diseases.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalJournal of Clinical Investigation
Volume111
Issue number1
DOIs
Publication statusPublished - 2003 Jan 1

Fingerprint

Allergic Conjunctivitis
Transglutaminases
Phospholipases A2
Annexin A1
Uteroglobin
Inflammation
Anti-Inflammatory Agents
Peptides
Elafin
Ambrosia
Annexins
Conserved Sequence
Guinea Pigs
transglutaminase 2
Research
Pharmaceutical Preparations
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sohn, Joonhong ; Kim, Tae-im ; Yoon, Young Hee ; Kim, Joo Yong ; Kim, Soo Youl. / Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. In: Journal of Clinical Investigation. 2003 ; Vol. 111, No. 1. pp. 121-128.
@article{b3058c2d22a241058462c661f4dc4893,
title = "Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis",
abstract = "Steroidal anti-inflammatory drugs induce proteins that inhibit phospholipase A2 (PLA2), including uteroglobin and lipocortin-1 (annexin I). Uteroglobin and lipocortin-1 retain several conserved sequences. Based on these sequences, several nonapeptides (antiflammins) were synthesized. These nonapeptides were shown to have anti-inflammatory effects in vitro and in vivo, possibly by inhibiting PLA2. Subsequent research showed that PLA2 is activated by transglutaminase 2 (TGase 2). We hypothesize here that TGase 2 inhibitors may increase the anti-inflammatory efficacy of inhibiting PLA2 activity. To test this theory, we constructed recombinant peptides containing sequences from pro-elafin (for inhibition of TGase 2), and from lipocortin-1, lipocortin-5, and uteroglobin (for inhibition of PLA2). The recombinant peptides, which had dual inhibitory effects on purified TGase 2 and PLA2, reversed the inflammation of allergic conjunctivitis to ragweed in a guinea pig model. The present work suggests that novel recombinant peptides may be safe and effective agents for the treatment of various inflammatory diseases.",
author = "Joonhong Sohn and Tae-im Kim and Yoon, {Young Hee} and Kim, {Joo Yong} and Kim, {Soo Youl}",
year = "2003",
month = "1",
day = "1",
doi = "10.1172/JCI200315937",
language = "English",
volume = "111",
pages = "121--128",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. / Sohn, Joonhong; Kim, Tae-im; Yoon, Young Hee; Kim, Joo Yong; Kim, Soo Youl.

In: Journal of Clinical Investigation, Vol. 111, No. 1, 01.01.2003, p. 121-128.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis

AU - Sohn, Joonhong

AU - Kim, Tae-im

AU - Yoon, Young Hee

AU - Kim, Joo Yong

AU - Kim, Soo Youl

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Steroidal anti-inflammatory drugs induce proteins that inhibit phospholipase A2 (PLA2), including uteroglobin and lipocortin-1 (annexin I). Uteroglobin and lipocortin-1 retain several conserved sequences. Based on these sequences, several nonapeptides (antiflammins) were synthesized. These nonapeptides were shown to have anti-inflammatory effects in vitro and in vivo, possibly by inhibiting PLA2. Subsequent research showed that PLA2 is activated by transglutaminase 2 (TGase 2). We hypothesize here that TGase 2 inhibitors may increase the anti-inflammatory efficacy of inhibiting PLA2 activity. To test this theory, we constructed recombinant peptides containing sequences from pro-elafin (for inhibition of TGase 2), and from lipocortin-1, lipocortin-5, and uteroglobin (for inhibition of PLA2). The recombinant peptides, which had dual inhibitory effects on purified TGase 2 and PLA2, reversed the inflammation of allergic conjunctivitis to ragweed in a guinea pig model. The present work suggests that novel recombinant peptides may be safe and effective agents for the treatment of various inflammatory diseases.

AB - Steroidal anti-inflammatory drugs induce proteins that inhibit phospholipase A2 (PLA2), including uteroglobin and lipocortin-1 (annexin I). Uteroglobin and lipocortin-1 retain several conserved sequences. Based on these sequences, several nonapeptides (antiflammins) were synthesized. These nonapeptides were shown to have anti-inflammatory effects in vitro and in vivo, possibly by inhibiting PLA2. Subsequent research showed that PLA2 is activated by transglutaminase 2 (TGase 2). We hypothesize here that TGase 2 inhibitors may increase the anti-inflammatory efficacy of inhibiting PLA2 activity. To test this theory, we constructed recombinant peptides containing sequences from pro-elafin (for inhibition of TGase 2), and from lipocortin-1, lipocortin-5, and uteroglobin (for inhibition of PLA2). The recombinant peptides, which had dual inhibitory effects on purified TGase 2 and PLA2, reversed the inflammation of allergic conjunctivitis to ragweed in a guinea pig model. The present work suggests that novel recombinant peptides may be safe and effective agents for the treatment of various inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=0037252190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037252190&partnerID=8YFLogxK

U2 - 10.1172/JCI200315937

DO - 10.1172/JCI200315937

M3 - Article

VL - 111

SP - 121

EP - 128

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -